Medical supply and logistics company Owens & Minor (NYSE:OMI) will be reporting earnings tomorrow morning. Here’s what to expect.
Owens & Minor beat analysts’ revenue expectations by 1.9% last quarter, reporting revenues of $2.72 billion, up 5% year on year. It was a slower quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates.
Is Owens & Minor a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Owens & Minor’s revenue to grow 1.1% year on year to $2.69 billion, slowing from the 4.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.52 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Owens & Minor has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Owens & Minor’s peers in the healthcare providers & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Cardinal Health’s revenues decreased 3.8% year on year, beating analysts’ expectations by 0.9%, and McKesson reported revenues up 17.8%, falling short of estimates by 0.7%. Cardinal Health traded down 3.2% following the results while McKesson was also down 1.1%.
Read our full analysis of Cardinal Health’s results here and McKesson’s results here.
Valuation multiples for many growth stocks have not yet reverted to their early 2021 highs, but the market has been optimistic as of late due to a soft landing. This is an economic situation where rate hikes successfully quelled inflation but did not send the economy into a recession. Furthermore, recent rate cuts and Donald Trump’s triumph in the 2024 Presidential election have been tailwinds for the market, and while some of the healthcare providers & services stocks have shown solid performance, the group has generally underperformed, with share prices down 4.4% on average over the last month. Owens & Minor is down 53.9% during the same time and is heading into earnings with an average analyst price target of $12.17 (compared to the current share price of $6.88).
Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
